SLAS DISCOVERY · 2011 · 28 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryEnzymologyEnzyme InhibitionGastroesophageal Reflux DiseaseGastrointestinal PharmacologyIon Channel PharmacologyLead Compound DesignAcid Secretion InhibitionGastric SecretionGastroesophageal Reflux Disease PharmacotherapyProton Pump ActivityProton Pump FunctionProton Pump InhibitionPyrrole Chemistry
H(+),K(+)-ATPase is a key enzyme in the process of gastric acid secretion, and proton pump inhibitors (PPIs) have been accepted as one of the most effective treatments for peptic ulcer and gastroesophageal reflux disease. To discover a novel class of PPIs, the authors screened a low-molecular-weight compound library and identified two prospective acid blockers that were pyrrole derivatives. Both compounds inhibited H(+),K(+)-ATPase in a reversible and potassium-competitive manner. These compounds led to the development of TAK-438 (1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate), which is currently undergoing clinical trials as a novel potassium-competitive acid blocker for the treatment of acid-related diseases.
22
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Cyrus H. Fiske, Y. Subbarow · Journal of Biological Chemistry · 1925 · 19.1K citations · Full text
A nonelectrogenic H+ pump in plasma membranes of hog stomach.
George Sachs, H. H. Chang, E. Rabon et al. · Journal of Biological Chemistry · 1976 · 602 citations · Full text
The mechanism of action of the antisecretory agent omeprazole
P. A. P. Lindberg, Peter Nordberg, Tomas Alminger et al. · Journal of Medicinal Chemistry · 1986 · 307 citations